597 related articles for article (PubMed ID: 18664156)
21. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.
Bensignor E; Olivry T
Vet Dermatol; 2005 Feb; 16(1):52-60. PubMed ID: 15725106
[TBL] [Abstract][Full Text] [Related]
22. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis.
Belsito D; Wilson DC; Warshaw E; Fowler J; Ehrlich A; Anderson B; Strober BE; Willetts J; Rutledge ES
J Am Acad Dermatol; 2006 Jul; 55(1):40-6. PubMed ID: 16781290
[TBL] [Abstract][Full Text] [Related]
23. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study.
Rigopoulos D; Gregoriou S; Charissi C; Kontochristopoulos G; Kalogeromitros D; Georgala S
Br J Dermatol; 2006 Jul; 155(1):152-5. PubMed ID: 16792767
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
[TBL] [Abstract][Full Text] [Related]
25. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
26. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.
Hebert AA; Koo J; Fowler J; Berman B; Rosenberg C; Levitt J
Cutis; 2006 Nov; 78(5):357-63. PubMed ID: 17186796
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a skin-protective foam in the treatment of chronic hand dermatitis.
Fowler JF
Am J Contact Dermat; 2000 Sep; 11(3):165-9. PubMed ID: 11012005
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus ointment: new preparation. Too many unknowns.
Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus ointment in the treatment of eyelid dermatitis.
Freeman AK; Serle J; VanVeldhuisen P; Lind L; Clarke J; Singer G; Lebwohl M
Cutis; 2004 Apr; 73(4):267-71. PubMed ID: 15134327
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.
Draelos Z; Nayak A; Pariser D; Shupack JL; Chon K; Abrams B; Paul CF
J Am Acad Dermatol; 2005 Oct; 53(4):602-9. PubMed ID: 16198779
[TBL] [Abstract][Full Text] [Related]
31. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
[TBL] [Abstract][Full Text] [Related]
32. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study.
Duque MI; Yosipovitch G; Fleischer AB; Willard J; Freedman BI
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):519-21. PubMed ID: 15761435
[TBL] [Abstract][Full Text] [Related]
33. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
Fleischer AB; Abramovits W; Breneman D; Jaracz E;
J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
[TBL] [Abstract][Full Text] [Related]
35. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis.
Saripalli YV; Gadzia JE; Belsito DV
J Am Acad Dermatol; 2003 Sep; 49(3):477-82. PubMed ID: 12963912
[TBL] [Abstract][Full Text] [Related]
38. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.
Boguniewicz M; Fiedler VC; Raimer S; Lawrence ID; Leung DY; Hanifin JM
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):637-44. PubMed ID: 9802373
[TBL] [Abstract][Full Text] [Related]
39. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
[TBL] [Abstract][Full Text] [Related]
40. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
